10 best shares to buy today
Get your Free Report on Top 5 ASX stocks for 2026
The following are the top 10 best ASX shares to buy today because they have a combination of price momentum along with long-term growth opportunities across multiple high potential industries.
10 best shares to buy today australia
- Xero Limited (ASX: XRO)Β
- 4DMedical Limited (ASX: 4DX)Β
- Weebit Nano Limited (ASX: WBT)
- Dateline Resources Limited (ASX: DTR)Β
- Megaport Limited (ASX: MP1)Β
- Asara Resources Limited (ASX: AS1)Β
- DroneShield Limited (ASX: DRO)Β
- GenusPlus Group Limited (ASX: GNP)Β
- American Rare Earths Limited (ASX: ARR)
- Tasmea Limited (ASX: TEA)Β
Xero Limited (ASX: XRO)Β
has a market capitalisation of $13.66 billion and is one of the best ASX shares to buy today because of its solid business model along with a compelling valuation.
The company in FY26 reported an impressive result as operating rose rising 31% year-on-year to NZ$2.75 billion while Adjusted EBITDA grew 18% to NZ$757 million.
The stock is undervalued because it has fallen 56% over the past 12 months while Xeroβs investment case is highly attractive due to its recurring revenue SaaS model and its dominant position in small business accounting software.
4DMedical Limited (ASX: 4DX)Β
has a market capitalisation of $2.4 billion and is one of the most promising ASX healthcare technology companies because the company is rapidly commercialising its revolutionary CT:VQ lung imaging platform.
The investment case for 4DMedical is compelling as CT:VQ is the worldβs first non-contrast CT based ventilation perfusion imaging technology.
The company also has a very strong financial position with a pro forma cash balance of $282.7 million after successful institutional capital raisings which places 4DMedical in a strong position to accelerate its commercial expansion.
Weebit Nano Limited (ASX: WBT)
has a market capitalisation of about $1.58 billion and is one of the most exciting semiconductor technology companies on the ASX after major commercial and technical breakthroughs in next-generation memory solutions.
The company on 4 May 2026 announced that two product customers had successfully taped-out chip designs using its advanced ReRAM technology which represents an important step towards future mass production.
Weebit Nano on 30 April 2026 announced an $87 million capital raise which improved its balance sheet and also increased its FY26 revenue guidance to at least $12 million from the earlier forecast of $10 million.
Dateline Resources Limited (ASX: DTR)Β
has a market capitalisation of $804.3 million and has attracted investor interest because of the company's Colosseum Gold-REE Project in California.
Recent drilling results were highly encouraging with broad gold intersections of 287.3m at 1.05g/t Au and 214m at 1.06g/t Au identified at the North Pit extension while management stated that the mineralisation remains open and extends beyond the current mineral resource envelope.
The company on 11 May 2026 announced that the BFS economics for the Colosseum Gold Project delivered a pre-tax NPV5 of US$785 million and a pre-tax IRR of 49.5% based on a gold price of US$4,200/oz.
Megaport Limited (ASX: MP1)Β
has a market capitalisation of approximately $2.33 billion and is emerging as one of the strongest AI infrastructure and network connectivity growth stories on the ASX.
The company recently secured major compute, network and storage contracts which have a combined contract value of approximately $254 million.
Megaport acts as the βpicks and shovelsβ provider for AI infrastructure which positions the company well to benefit from long-term AI tailwinds.
Asara Resources Limited (ASX: AS1)Β
is a compelling West African gold exploration company because it continues to rapidly advance its flagship Kada Gold Project in Guinea where ongoing drilling has expanded the gold resource base and improved confidence in the resource estimate.
The company recently improved its financial position through a $60 million capital raising which management said will fast track exploration activities along with mine infrastructure works and technical studies across the project.
The investment case for AS1 is attractive as the company already hosts a sizeable 923000-ounce gold resource at Kada while a significant part of the broader 150 square km land package remains underexplored which creates potential for additional discoveries and future resource growth.
DroneShield Limited (ASX: DRO)Β
has become one of the worldβs leading counter-drone technology companies because global defence spending is rising and demand for AI-powered anti-drone systems is increasing a lot.
The company in 1Q26 delivered exceptionally strong results with revenue rising 121% year-on-year to $74.1 million while customer cash receipts climbed 360% to a record $77.4 million.
The investment rationale for DRO appears highly compelling as geopolitical conflicts and rising infrastructure security threats have created a structural long-term demand cycle for counter-drone solutions.
GenusPlus Group Limited (ASX: GNP)Β
is as one of the strongest infrastructure and energy transition growth stories on the ASX because the company benefits from the massive long term investment cycle in Australia's energy infrastructure.
The company in HY2026 delivered an exceptional result as revenue surged 61% year-on-year to $535.4 million while statutory NPAT increased 82% to $24.9 million and operating cash flow rose 201% to $73.7 million which also helped expand the orderbook to a record $2.4 billion.
The business is in a very strong financial position with cash of $178.1 million while management targets acquisitions and additional expansion opportunities across the rapidly growing energy infrastructure market.
American Rare Earths Limited (ASX: ARR)
has emerged as one of the most strategically important critical minerals companies on the ASX because of the Halleck Creek Rare Earths Project in Wyoming which has the potential to become a key supplier to the United States domestic rare earth supply chain.
The company recently accelerated project development through a Wyoming-led pilot plant pathway towards pre-production rare earth oxide while also advancing downstream oxide-to-metal studies and progressing work for completion of its Pre-Feasibility Study in late Q3 2026.
ARRβs investment rationale is highly compelling as the company offers direct exposure to rising geopolitical demand for secure Western rare earth supply chains.
Tasmea Limited (ASX: TEA)Β
has emerged as one of the more compelling industrial growth stories on the ASX after posting a very strong HY26 result which was supported by both organic growth and its successful acquisition strategy.
The company recorded statutory revenue growth of 62% to $400.5 million while underlying EBIT rose 36% to $44.3 million and underlying NPAT increased 32% to $26.6 million which reflects the resilience of its diversified maintenance-focused business model.
Tasmea will benefit from strong long-term industry tailwinds while management also reaffirmed FY26 EBIT guidance of $117 million.
(Source: Company Reports)
Get Your Free Report on Top 5 ASX Stocks on WhatsApp
Instant Access. No Credit Card Required.
Receive on WhatsApp
Checkout Our Recommendation for free - 7 days free trial
Start Free TrialASX Stock Research & Recommendations β 7βday free trial
Independent, analystβdriven insights.
- Stock of the week report
- Daily Analysis Report
- No credit card required
Get Your FREE Report
Discover the Top ASX Stocks to Invest In 2026!
Expert Analysis of Top-Performing ASX Stocks
Market Insights and In-Depth Research
Buy, Sell, And Hold Recommendations
Almost There!
Enter your details to download the report
Success!
Preparing your download...
Latest Article
Disclaimer
Veye Pty Ltd(ABN 58 623 120 865), holds (AFSL No. 523157 ). All information provided by Veye Pty Ltd through its website, reports, and newsletters is general financial product advice only and should not be considered a personal recommendation to buy or sell any asset or security. Before acting on the advice, you should consider whether itβs appropriate to you, in light of your objectives, financial situation, or needs. You should look at the Product Disclosure Statement or other offer document associated with the security or product before making a decision on acquiring the security or product. You can refer to our Terms & Conditions and Financial Services Guide for more information. Any recommendation contained herein may not be suitable for all investors as it does not take into account your personal financial needs or investment objectives. Although Veye takes the utmost care to ensure accuracy of the content and that the information is gathered and processed from reliable resources, we strongly recommend that you seek professional advice from your financial advisor or stockbroker before making any investment decision based on any of our recommendations. All the information we share represents our views on the date of publishing as stocks are subject to real time changes and therefore may change without notice. Please remember that investments can go up and down and past performance is not necessarily indicative of future returns. We request our readers not to interpret our reports as direct recommendations. To the extent permitted by law, Veye Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss, or data corruption) (as mentioned on the website www.veye.com.au), and confirms that the employees and/or associates of Veye Pty Ltd do not hold positions in any of the financial products covered on the website on the date of publishing this report. Veye Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services.